These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32017014)

  • 21. A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome.
    Stepan H; Hund M; Gencay M; Denk B; Dinkel C; Kaminski WE; Wieloch P; Semus B; Meloth T; Dröge LA; Verlohren S
    Hypertens Pregnancy; 2016 Aug; 35(3):295-305. PubMed ID: 27028698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can maternal serum placental growth factor estimation in early second trimester predict the occurrence of early onset preeclampsia and/or early onset intrauterine growth restriction? A prospective cohort study.
    Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
    J Obstet Gynaecol Res; 2013 May; 39(5):881-90. PubMed ID: 23496304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction.
    Sibiude J; Guibourdenche J; Dionne MD; Le Ray C; Anselem O; Serreau R; Goffinet F; Tsatsaris V
    PLoS One; 2012; 7(11):e50208. PubMed ID: 23209675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of Timing First-Trimester Placental Growth Factor and Use of Serial First-Trimester Placental Growth Factor Measurements in Screening for Preeclampsia.
    Mosimann B; Amylidi-Mohr S; Höland K; Surbek D; Risch L; Raio L
    Fetal Diagn Ther; 2017; 42(2):111-116. PubMed ID: 28199996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
    Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis.
    Frampton GK; Jones J; Rose M; Payne L
    Health Technol Assess; 2016 Nov; 20(87):1-160. PubMed ID: 27918253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
    Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rule-in thresholds for DELFIA Xpress PlGF 1-2-3 test for suspected pre-eclampsia.
    Giblin L; McCarthy FP; Gill C; Seed PT; Bramham K; Brockbank A; Chappell LC; Shennan AH
    Pregnancy Hypertens; 2020 Jul; 21():35-37. PubMed ID: 32388118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Placental growth factor: a predictive marker for preeclampsia?
    Schmidt M; Dogan C; Birdir C; Kuhn U; Gellhaus A; Kimmig R; Kasimir-Bauer S
    Gynakol Geburtshilfliche Rundsch; 2009; 49(2):94-9. PubMed ID: 19346754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany.
    Schlembach D; Hund M; Schroer A; Wolf C
    BMC Health Serv Res; 2018 Aug; 18(1):603. PubMed ID: 30081904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia: INSPIRE.
    Cerdeira AS; O'Sullivan J; Ohuma EO; Harrington D; Szafranski P; Black R; Mackillop L; Impey L; Greenwood C; James T; Smith I; Papageorghiou AT; Knight M; Vatish M
    Hypertension; 2019 Oct; 74(4):983-990. PubMed ID: 31401877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline placental growth factor levels for the prediction of benefit from early aspirin prophylaxis for preeclampsia prevention.
    Moore GS; Allshouse AA; Winn VD; Galan HL; Heyborne KD
    Pregnancy Hypertens; 2015 Oct; 5(4):280-6. PubMed ID: 26597741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of preeclampsia in primigravida in late first trimester using serum placental growth factor alone and by combination model.
    Agarwal R; Chaudhary S; Kar R; Radhakrishnan G; Tandon A
    J Obstet Gynaecol; 2017 Oct; 37(7):877-882. PubMed ID: 28569565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of imminent preeclampsia at 35-37 weeks gestation.
    Ciobanu A; Wright A; Panaitescu A; Syngelaki A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2019 Jun; 220(6):584.e1-584.e11. PubMed ID: 30738886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Placental growth factor in assessment of women with suspected pre-eclampsia to reduce maternal morbidity: a stepped wedge cluster randomised control trial (PARROT Ireland).
    Hayes-Ryan D; Khashan AS; Hemming K; Easter C; Devane D; Murphy DJ; Hunter A; Cotter A; McAuliffe FM; Morrison JJ; Breathnach FM; Dempsey E; Kenny LC; O'Donoghue K;
    BMJ; 2021 Aug; 374():n1857. PubMed ID: 34389547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary and Serum Angiogenic Markers in Women With Preexisting Diabetes During Pregnancy and Their Role in Preeclampsia Prediction.
    Zen M; Padmanabhan S; Zhang K; Kirby A; Cheung NW; Lee VW; Alahakoon TI
    Diabetes Care; 2020 Jan; 43(1):67-73. PubMed ID: 31601637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Placental Growth Factor (PlGF) in Women with Suspected Pre-Eclampsia Prior to 35 Weeks' Gestation: A Budget Impact Analysis.
    Duckworth S; Chappell LC; Seed PT; Mackillop L; Shennan AH; Hunter R
    PLoS One; 2016; 11(10):e0164276. PubMed ID: 27741259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical value of angiogenic and anti-angiogenic marker assay in preeclampsia].
    Mccarey C; Baert J; Mathey MP; Martinez De Tejada B; Vial Y; Berkane N; Rieder W
    Rev Med Suisse; 2020 Oct; 16(712):2031-2036. PubMed ID: 33112515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of pre-eclampsia within 4 weeks of sFlt-1/PlGF ratio > 38: comparison of performance at 31-34 vs 35-37 weeks' gestation.
    Dragan I; Wright D; Fiolna M; Leipold G; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Feb; 49(2):209-212. PubMed ID: 27671743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addition of N-terminal pro-B natriuretic peptide to soluble fms-like tyrosine kinase-1/placental growth factor ratio > 38 improves prediction of pre-eclampsia requiring delivery within 1 week: a longitudinal cohort study.
    Sabriá E; Lequerica-Fernández P; Lafuente-Ganuza P; Eguia-Ángeles E; Escudero AI; Martínez-Morillo E; Barceló C; Álvarez FV
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):758-767. PubMed ID: 29498431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.